DCF — HCA HOUSTON HEALTHCARE TOMBALL
Enterprise Value: $10.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$10.0M
Enterprise Value
$-2.6M
PV of Cash Flows
$12.6M
PV of Terminal Value
$20.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $221.3M | $6.3M | 3.0% | $-3.2M | $-2.9M |
| Year 2 | $227.9M | $8.8M | 4.0% | $-1.6M | $-1.3M |
| Year 3 | $234.8M | $11.4M | 5.0% | $0.1M | $0.1M |
| Year 4 | $241.8M | $13.0M | 5.0% | $1.0M | $0.7M |
| Year 5 | $249.1M | $14.0M | 6.0% | $1.5M | $0.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $10.0M. Terminal value accounts for 126% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$214.9M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.023577726147255836
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5